FERRING LÆGEMIDLER A/S: Financial statements 2024
CVR: 16313491
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
FERRING LÆGEMIDLER A/S (CVR 16313491) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 6,279,000 and a net result of DKK 1,234,000 compared with DKK 1,155,000 the year before. That is a decrease of 8.1% compared with the year before. Equity in the 2024 report amounted to DKK 9,858,000. The solvency ratio was 25.8%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 6,279,000
- Profit/Loss
- DKK 1,234,000
- Equity
- DKK 9,858,000
- Total Assets
- DKK 38,147,000
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 6.3M | 1.2M | 9.9M | 3 |
| 2023 | - | 6.8M | 1.2M | 8.6M | 3 |
| 2022 | - | 5.7M | 1.5M | 12M | 2 |
| 2021 | - | 7.1M | 2.6M | 10.4M | 2 |
| 2020 | - | 15.1M | 1.1M | 7.9M | 10 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 10, 2024, Jenise Ryann Doutsas has joined the board of directors of FERRING LÆGEMIDLER A/S.
As of December 10, 2024, Lasse Juul Jakobsen has left the board of directors of FERRING LÆGEMIDLER A/S.
FERRING LÆGEMIDLER A/S has won the tender "Amgros 2025 1.1163.a" issued by Amgros I/S worth 1,644,000,000 DKK.
FERRING LÆGEMIDLER A/S has won the tender "Amgros 2025 1.700.a" issued by Amgros I/S worth 313,301,544 DKK.
FERRING LÆGEMIDLER A/S has won the tender "Amgros 2025 1.706.b" issued by Amgros I/S worth 25,800,000 DKK.
As of August 7, 2024, Mario Alejandro Esteves Durand has joined the board of directors of FERRING LÆGEMIDLER A/S.
As of August 7, 2024, Valerio Trifoni has left the board of directors of FERRING LÆGEMIDLER A/S.
As of July 30, 2024, Maja Lassenius Kramp is registered as adm. dir. of FERRING LÆGEMIDLER A/S.
As of July 30, 2024, Morten Vaupel has stepped down as adm. dir. of FERRING LÆGEMIDLER A/S.
FERRING LÆGEMIDLER A/S has published its annual report for 2023. Gross profit came to DKK 6,832,000, and the net result was DKK 1,155,000.
About FERRING LÆGEMIDLER A/S
FERRING LÆGEMIDLER A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE 38 NR. 1586. The management consists of Maja Lassenius Kramp. The board consists of Kjell Thomas Larsson (chair), Eric Michel Breumier and Valerio Trifoni. The company is owned by Ferring B.V.. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 6,653,000 and a net result of DKK 1,371,000 compared with DKK 1,234,000 the year before. Equity in the 2025 report amounted to DKK 11,229,000.
